A. A. Hassan et al./Chemical Papers 69 (7) 973–982 (2015)
975
Table 1. Spectral data of newly prepared compounds Va–Vj, VI, VIIa–VIIj and VIII
Compounda
Spectral data
IR, ν˜/cm−1: 995, 1348 (C S and C—N), 1565 (NH def. and C—N str.), 1590 (Ar-C C), 3110–3190, 3305 (NH2
—
—
—
—
Vd
and NH)
1H NMR (DMSO-d6), δ: 3.70 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 4.85 (br, 2H, NH2), 7.10 (s,
2H, Ar—CH), 7.91 (s, 1H, CH N), 9.84 (br, 1H, 4NH), 11.41 (br, 1H, 2NH)
—
—
13
—
—
C NMR (DMSO-d6), δ: 56.04, 56.06, 59.98 (OCH3), 129.51 (Ar—CH), 138.75 (Ar—C), 141.91 (CH N), 152.87
—
(Ar—C—O), 175.87 (C S)
—
MS, m/z (Ir/%): 284 (100) (M+), 258 (24), 210 (62), 195 (88), 136 (16)
—
—
Vg
Vh
Vj
IR, ν˜/cm−1: 990, 1358 (C S and C—N), 1560 (NH def. and C—N str.), 1585 (Ar—C C), 3120–3254, 3315 (NH2
—
—
and NH)
1H NMR (DMSO-d6), δ: 4.96 (br, 2H, NH2), 7.42–7.78 (m, 4H, Ar-CH), 7.90–8.15 (m, 3H, Ar-CH), 8.31 (s, 1H,
CH N), 9.83 (br, 1H, 4NH), 11.46 (br, 1H, 2NH)
—
—
13C NMR (DMSO-d6), δ: 127.07, 127.75, 128.55, 129.12, 129.78 (A-CH), 130.30, 133.13, 133.27 (Ar-C), 140.32
—
—
(CH N), 175.58 (C S)
—
—
MS, m/z (Ir/%): 244 (44) (M+), 169 (25), 154 (100), 127 (62)
IR, ν˜/cm−1: 996, 1348 (C S and C—N), 1565 (NH def. and C—N str.), 1590 (Ar-C C), 3140–3235, 3330 (NH2
—
—
—
—
and NH)
1H NMR (DMSO-d6), δ: 4.96 (br, 2H, NH2), 7.52–7.68 (m, 6H, Ar-CH), 8.15–8.22 (m, 3H, Ar-CH), 8.43 (s, 1H,
CH N), 9.72 (br, 1H, 4NH), 11.37 (br, 1H, 2NH)
—
—
13C NMR (DMSO-d6), δ: 125.14, 125.54, 127.16, 128.87, 129.25, 129.57 (Ar-CH), 130.26, 130.83, 133.95, 134.16
—
—
(Ar-C), 141.74 (CH N), 176.12 (C S)
—
—
MS, m/z (Ir/%): 294 (17) (M+), 219 (22), 203 (100), 177 (43)
IR, ν˜/cm−1: 995, 1343 (C S and C—N), 1568 (NH def. and C—N str.), 2946 (Ali-CH), 3195, 3437 (NH2 and NH)
1H NMR (DMSO-d6), δ: 0.86 (t, 3H, CH3, J = 7.62), 1.22–1.31 (m, 6H, 3 CH2), 1.39–1.43 (m, 2H, CH2), 4.75 (br,
—
—
2H, NH2), 7.18 (s, 1H, CH N), 9.23 (br, 1H, 4NH), 10.93 (br, 1H, 2NH)
—
—
13
—
—
—
—
C NMR (DMSO-d6), δ: 13.86 (CH3), 21.96, 24.78, 29.67, 31.12 (CH2), 66.12 (CH N), 172.53 (C S)
MS, m/z (Ir/%): 188 (81) (M+), 117 (100), 75 (93), 60 (98)
13C NMR (DMSO-d6), δ: 33.19 (CH2), 51.96, 52.55, 52.68 (OCH3), 116.38 (vinyl-CH), 138.75 (thiazolidine-C5),
VI
—
—
—
153.05 (acyclic C N), 161.68 (thiazolidine-C2), 162.69 (cyclic C O), 163.43, 165.43, 168.30 (ester-C O)
—
—
—
—
—
VIIa
IR, ν˜/cm−1: 1605 (Ar-C C), 1625 (C N), 1690, 1705, 1715, 1730 (CO)
—
—
1H NMR (CDCl3), δ: 3.64 (s, 2H, CH2), 3.83 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 6.86 (s, 1H,
—
vinyl-CH), 7.46–7.53 (m, 2H, Ar-H), 7.73–7.78 (m, 2H, Ar-H), 8.33 (s, 1H, CH N)
—
13C NMR (CDCl3), δ: 33.16 (CH2), 52.11, 52.49, 52.61 (OCH3), 116.52 (vinyl-CH), 127.94, 128.76 (Ar-CH), 133.31,
—
—
135.86 (Ar-C), 139.12 (thiazolidine-C5), 141.81 (CH N), 152.12 (acyclic C N), 160.93 (thiazolidine-C2), 163.12
—
—
—
—
—
(cyclic C O), 163.84, 165.66, 167.86 (ester-C O).
—
MS, m/z (Ir/%): 480/482 (12) (M+), 449 (16), 390 (22), 287 (26), 193 (12), 153 (34), 125 (82), 59 (100)
—
—
VIIb
VIIc
VIId
IR, ν˜/cm−1: 1595 (Ar-C C), 1630 (C N), 1688,1695, 1715, 1725 (C O)
— —
— —
1H NMR (CDCl3), δ: 3.62 (s, 2H, CH2), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.88 (s, 3H,
—
OCH3), 6.85 (s, 1H, vinyl-CH), 7.40–7.55 (m, 2H, Ar-H), 7.70–7.84 (m, 2H, Ar-H), 8.28 (s, 1H, CH N)
—
13C NMR (CDCl3), δ: 33.11 (CH2), 51.89, 52.14, 52.59, 52.66 (OCH3), 116.46 (vinyl-CH), 125.72, 126.63 (Ar-
—
—
—
CH), 132.61 (Ar-C), 139.08 (thiazolidine-C5), 141.65 (CH N), 152.29 (acyclic C N), 153.44 (Ar-C—O) 159.87
—
—
—
—
(thiazolidine-C2), 163.31 (cyclic C O), 164.12, 165.66, 167.84 (ester-C O).
—
MS, m/z (Ir/%): 476 (12) (M+), 332 (16), 144 (17), 133 (100), 91 (53), 59 (22)
IR, ν˜/cm−1: 1604 (Ar-C C), 1626 (C N), 1700, 1690, 1710, 1728 (C O)
—
—
—
—
—
—
1H NMR (CDCl3), δ: 3.61 (s, 2H, CH2), 3.81 (s, 6H, 2OCH3), 3.83 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.89 (s, 3H,
—
OCH3), 6.87 (s, 1H, vinyl-CH), 7.14–7.49 (m, 3H, Ar-H), 8.34 (s, 1H, CH N)
—
13C NMR (CDCl3), δ: 32.41 (CH2), 51.86, 52.34, 52.39, 55.67, 57.63 (OCH3), 116.81 (vinyl-CH), 124.96, 125.32,
—
—
126.14 (Ar-CH), 132.16 (Ar-C), 139.28 (thiazolidine-C5), 141.96 (CH N), 151.84 (acyclic C N), 152.68 (Ar-C—O),
160.76 (thiazolidine-C2), 163.52 (cyclic C O), 164.12, 165.66, 168.14 (ester-C O)
MS, m/z (Ir/%): 506 (14) (M+), 475 (19), 413 (11), 351 (36), 164 (100), 148 (28), 120 (19), 92 (36), 59 (44)
—
—
—
—
—
—
IR, ν˜/cm−1: 1605 (Ar-C C), 1625 (C N), 1696,1700, 1715, 1728 (C O)
—
—
—
—
—
—
1H NMR (CDCl3), δ: 3.59 (s, 2H, CH2), 3.83 (s, 6H, 2OCH3), 3.84 (s, 3H, 2OCH3), 3.85 (s, 3H, OCH3), 3.87 (s,
—
3H, OCH3), 3.89 (s, 3H, OCH3), 6.85 (s, 1H, vinyl-CH), 7.10–7.12 (m, 2H, Ar-H), 8.38 (s, 1H, CH N)
—
13C NMR (CDCl3) δ: 33.88 (CH2), 51.93, 52.46, 52.59, 56.22, 56.34, 60.99 (OCH3), 116.78 (vinyl-CH), 127.60 (Ar-
—
—
CH), 129.96 (Ar-C), 140.12 (thiazolidine-C5), 141.16 (CH N), 153.48 (acyclic C N), 154.14 (Ar-C—O), 160.89
—
—
—
—
—
(thiazolidine-C2), 163.12 (cyclic C O), 165.39, 166.41, 167.92 (ester-C O)
MS, m/z (Ir/%): 536 (54) (M+), 359 (11), 218 (22), 180 (23), 91 (100), 59 (48)
—
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 5/23/15 9:21 PM